The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
Texas MPN Workshop 2022 | Unmet needs in ET and future considerations
Aaron Gerds, MD, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, briefly discusses unmet needs in essential thrombocythemia (ET), highlighting the importance of identifying patient risk for thrombotic events, and improving therapeutic options for patients. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.
Disclosures
Consulting/Advisory for CTI Biopharma, GSK/Sierra Oncology, Morphosys, ParmaEssentia, Imago, AbbVie
